Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026)
Advanced Biomed (ADVB) posted Return on Capital Employed of 120.92% for Q1 2026, down 21.5% sequentially from 154.04% in Q4 2025, and down 4020.0% YoY from 3.08% in Q1 2025.
Advanced Biomed (ADVB) Return on Capital Employed (2025 - 2026) Analysis & Trends
Advanced Biomed has reported Return on Capital Employed for 2 years, with the latest figure at 120.92% in Q1 2026.
- Quarterly Return on Capital Employed fell 4020.0% year-over-year to 120.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 120.92% (down 4020.0% YoY) and the FY2025 annual result came in at 159.13%, changed N/A from the prior year.
- Return on Capital Employed declined to 120.92% in Q1 2026 per ADVB's latest filing, from 154.04% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 161.12% in Q1 2025 and troughed at 58.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Advanced Biomed | 10.46 Mn | 10.46 Mn | - | 120.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.92% |
| Dec 31, 2025 | 154.04% |
| Sep 30, 2025 | 58.06% |
| Jun 30, 2025 | 134.11% |
| Mar 31, 2025 | 161.12% |